Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.

GLP-1 maintenance after medication

Most GLP-1 trials show meaningful weight regain when patients stop the medication. The maintenance question is the most important one in this category, and most programs answer it badly or not at all. Honesty about regain risk is itself a signal.

Written by

WeighedHealth Editorial Team

Editorial team-reviewed

Against primary clinical sources
Last reviewed July 2026

Who this guide is for

Patients approaching their target weight, evaluating long-term cost, or who have already stopped a GLP-1 and want behavioral support to maintain.

How we ranked

We rank by whether the program retains value if you stop the medication. Structured taper protocol, peer community that survives Rx exit, dietitian access without active Rx all count.

No GLP-1 program currently scores meaningfully on this dimension

This is itself a finding. If you need this layer, weigh it heavily against any program's price tier.

Other behavioral lenses